Alexandria Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $10.9M | Sell |
47,116
-10
| -0% | -$2.47K | 1.01% | 21 |
|
|
2021
Q2 | $10.8M | Sell |
47,126
-167
| -0.4% | -$33.5K | 1% | 22 |
|
|
2021
Q1 | $8.84M | Sell |
47,293
-45
| -0.1% | -$8.8K | 0.89% | 32 |
|
|
2020
Q4 | $7.99M | Sell |
47,338
-17
| -0% | -$2.54K | 0.85% | 35 |
|
|
2020
Q3 | $7.01M | Sell |
47,355
-165
| -0.3% | -$25.5K | 0.84% | 35 |
|
|
2020
Q2 | $7.8M | Sell |
47,520
-138
| -0.3% | -$21.2K | 1.01% | 27 |
|
|
2020
Q1 | $6.61M | Sell |
47,658
-311
| -0.6% | -$42.7K | 1.08% | 27 |
|
|
2019
Q4 | $6.3M | Hold |
47,969
| – | – | 0.84% | 32 |
|
|
2019
Q3 | $5.36M | Sell |
47,969
-250
| -0.5% | -$27.8K | 0.79% | 34 |
|
|
2019
Q2 | $5.34M | Sell |
48,219
-1,529
| -3% | -$180K | 0.76% | 34 |
|
|
2019
Q1 | $6.46M | Sell |
49,748
-5,964
| -11% | -$725K | 0.94% | 30 |
|
|
2018
Q4 | $6.45M | Buy |
55,712
+767
| +1% | +$85.7K | 1.05% | 26 |
|
|
2018
Q3 | $5.9M | Hold |
54,945
| – | – | 0.87% | 33 |
|
|
2018
Q2 | $4.69M | Hold |
54,945
| – | – | 0.7% | 40 |
|
|
2018
Q1 | $4.25M | Hold |
54,945
| – | – | 0.63% | 50 |
|
|
2017
Q4 | $4.64M | Buy |
54,945
+54,665
| +19,523% | +$4.65M | 0.68% | 43 |
|
|
2017
Q3 | $24K | Hold |
280
| – | – | 0.01% | 333 |
|
|
2017
Q2 | $23K | Hold |
280
| – | – | 0.01% | 341 |
|
|
2017
Q1 | $24K | Hold |
280
| – | – | 0.01% | 323 |
|
|
2016
Q4 | $21K | Buy |
280
+180
| +180% | +$13.4K | 0.01% | 341 |
|
|
2016
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 438 |
|
|
2016
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 438 |
|
|
2016
Q1 | $7K | Sell |
100
-100
| -50% | -$7.57K | ﹤0.01% | 466 |
|
|
2015
Q4 | $17K | Buy |
+200
| New | +$16.6K | ﹤0.01% | 385 |
|
|
2015
Q2 | – | Sell |
-534
| Closed | -$39K | – | 627 |
|
|
2015
Q1 | $39K | Buy |
534
+470
| +734% | +$33.5K | 0.01% | 226 |
|
|
2014
Q4 | $4K | Hold |
64
| – | – | ﹤0.01% | 481 |
|
|
2014
Q3 | $4K | Sell |
64
-26
| -29% | -$1.65K | ﹤0.01% | 465 |
|
|
2014
Q2 | $6K | Hold |
90
| – | – | ﹤0.01% | 421 |
|
|
2014
Q1 | $5K | Sell |
90
-33
| -27% | -$1.84K | ﹤0.01% | 453 |
|
|
2013
Q4 | $6K | Buy |
123
+42
| +52% | +$2.1K | ﹤0.01% | 428 |
|
|
2013
Q3 | $4K | Hold |
81
| – | – | ﹤0.01% | 488 |
|
|
2013
Q2 | $4K | Buy |
+81
| New | +$4.41K | ﹤0.01% | 523 |
|
Other funds holding LLY
Alexandria Capital's LLY Position: Q3 2021 in Review
Alexandria Capital reduced its Eli Lilly (LLY) stake by 0.02% in Q3 2021, selling an estimated $2.47K and leaving 47,116 shares worth $10.9M. The position accounts for 1.01% of the portfolio, ranked #21.
Alexandria Capital first reported a position in LLY in Q2 2013 and has held it in 32 quarters since. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.
- Alexandria Capital held 47,116 shares of Eli Lilly worth $10.9M as of Q3 2021.
- Alexandria Capital sold 10 Eli Lilly shares in Q3 2021, an estimated $2.47K.
- Eli Lilly made up 1.01% of Alexandria Capital's portfolio in Q3 2021, its #21 holding.
- Alexandria Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 32 quarters since.
- 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.